ストックスクリーナーアプリを入手
12.33
6.20%
0.72
アフターアワーズ：
12.33
Korro Bio Inc (KRRO) 最新ニュース
Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come - Bez Kabli
Korro Bio Inc. (KRRO) Surges Nearly 12% as Biotech Momentum BuildsExpert Momentum Signals - Newser
Korro Bio Selects KRRO-111 as RNA Editing Therapy Candidate for Alpha-1 Antitrypsin Deficiency (AATD) with Best-in-Class Preclinical Results 1 - Minichart
Korro Bio, Inc.Common Stock (NQ: KRRO - The Chronicle-Journal
Korro Bio adds AATD treatment candidate to pipeline By Investing.com - Investing.com South Africa
H.C. Wainwright cuts Korro Bio stock price target on financing impact By Investing.com - Investing.com South Africa
Korro Bio nominates new candidate for AATD - BioWorld News
H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Cuts Target Price to $15 - Moomoo
Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein - Traders Union
H.C. Wainwright cuts Korro Bio stock price target on financing impact - Investing.com Nigeria
Korro Bio Advances KRRO-111 for Alpha-1 Deficiency - TipRanks
Korro Bio adds AATD treatment candidate to pipeline - Investing.com
Citigroup initiates coverage of Korro Bio (KRRO) with buy recommendation - MSN
KRRO Initiates Coverage by Citigroup -- Announces Buy Rating - GuruFocus
Citi Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $21 - Moomoo
Lynx1 Capital Management LP's Korro Bio Inc(KRRO) Holding History - GuruFocus
Citigroup Initiates Korro Bio at Buy With $21 Price Target - marketscreener.com
Should You Sell Korro Bio (KRRO) After -8.12% Drop? 2026-05-15Stock Picks - Newser
Korro Bio, Inc. advances KRRO-121 RNA editing therapy for hyperammonemia toward clinical stage - Traders Union
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Korro Bio hire gets option for 3,000 shares at $11.20 - Stock Titan
TradingKey - TradingKey
Korro Bio (KRRO) Price Target Decreased by 30.76% to 66.30 - MSN
Korro announces oversubscribed $85 million private placement - MSN
Number of shareholders of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Korro Bio (NASDAQ:KRRO) Announces Quarterly Earnings Results - MarketBeat
Wave Life Sciences (WVE) Attracts Positive Attention Amid Compet - GuruFocus
JonesTrading Upgrades Korro Bio(KRRO.US) to Buy Rating, Announces Target Price $23 - Moomoo
Jones Trading upgrades Korro Bio stock rating on AATD program potential By Investing.com - Investing.com South Africa
Jones Trading upgrades Korro Bio stock rating on AATD program potential - Investing.com Nigeria
Chardan Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Korro Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Korro Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Korro Bio IncReports No Collaboration Reve - Moomoo
Korro Bio (KRRO) trims R&D spend and boosts cash to $157M - Stock Titan
Korro Bio, Inc. 1Q 2026: Revenue $0M, EPS $(1.69) — 10-Q Summary - TradingView
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Korro raises $85M, targets 2026 filing for rare-disease drug - Stock Titan
Korro Bio (Nasdaq: KRRO) boosts cash to $157M and targets 2026 KRRO-121 filing - Stock Titan
What Korro Bio (KRRO) management is not saying enough about (Technical Strength) 2026-05-06Top Trending Breakouts - newser.com
Korro CEO and top executives line up two investor fireside chats - Stock Titan
Korro to Participate in Upcoming Investor Conferences - marketscreener.com
Korro Bio executives to present at two major investor conferences in May 2026 - Pluang
Korro Bio Inc expected to post a loss of $1.84 a shareEarnings Preview - TradingView
What makes Korro Bio, Inc. (KRRO) a new buy stock - MSN
Korro Bio (KRRO) to Release Quarterly Earnings on Wednesday - MarketBeat
What Makes Korro Bio, Inc. (KRRO) a New Buy Stock - Yahoo Finance Australia
0.98%
0.12%
大文字化:
|
ボリューム (24 時間):